A456190 logo

Curachem XKON:A456190 Stock Report

Last Price

₩16.80k

Market Cap

₩29.5b

7D

0%

1Y

n/a

Updated

25 Nov, 2024

Data

Company Financials

A456190 Stock Overview

Provides services in custom carbon-14 radio labeling, stable isotope labeling, and medical chemistry and process development. More details

A456190 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Curachem Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Curachem
Historical stock prices
Current Share Price₩16,800.00
52 Week High₩21,000.00
52 Week Low₩16,320.00
Beta0
1 Month Change0%
3 Month Change0%
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO-4.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

A456190KR PharmaceuticalsKR Market
7D0%4.8%2.2%
1Yn/a1.8%-8.3%

Return vs Industry: Insufficient data to determine how A456190 performed against the KR Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how A456190 performed against the KR Market.

Price Volatility

Is A456190's price volatile compared to industry and market?
A456190 volatility
A456190 Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement5.5%
Market Average Movement6.6%
10% most volatile stocks in KR Market12.8%
10% least volatile stocks in KR Market3.4%

Stable Share Price: A456190's share price has been volatile over the past 3 months compared to the KR market.

Volatility Over Time: Insufficient data to determine A456190's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2009n/aSook-Jung Shinwww.curachem.com

Curachem Inc. provides services in custom carbon-14 radio labeling, stable isotope labeling, and medical chemistry and process development. Its custom carbon-14 radio labeling services include designing new synthetic routes for labeling at specified positions, multi-step and label synthesis, carbon-14 manifold for radio labeling with volatile radio chemicals, and stable isotope labeling synthesis. The company's medical chemistry and process development services comprise analyzing hit compounds, designing, and synthesizing focused libraries based on hits, analyzing SAR propose optimization plans, and molecular modeling and quantitative SAR for data analysis and drug design.

Curachem Inc. Fundamentals Summary

How do Curachem's earnings and revenue compare to its market cap?
A456190 fundamental statistics
Market cap₩29.47b
Earnings (TTM)₩0
Revenue (TTM)n/a

n/a

P/E Ratio

n/a

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A456190 income statement (TTM)
Revenue₩0
Cost of Revenue₩0
Gross Profit₩0
Other Expenses₩0
Earnings₩0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did A456190 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/11/25 07:25
End of Day Share Price 2024/08/29 00:00
EarningsN/A
Annual EarningsN/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Curachem Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution